Lenskart Launches Hooper Creatr: Customizable Kids’ Eyewear for Comfort and Myopia Control

Lenskart introduces Hooper Creatr, a new collection that allows kids to express their creativity and style through fully customizable eyewear. Designed specifically for young adventurers, Hooper Creatr transforms wearing glasses into a fun and personalized experience, turning eyewear from a necessity into a canvas for self-expression.

Hooper Creatr offers fully customizable frames, allowing kids the freedom to choose every detail—from adjustable temple tips to changeable nose pads and unbreakable Flexi hinges—ensuring both comfort and durability for active children. The soft, cushioned nose pads provide a snug, mark-free fit for all-day wear, making the frames both practical and fun.

What makes the collection truly unique is its thoughtful design, which goes beyond aesthetics to support vision health. As myopia in children becomes an increasing concern, these frames are specifically designed to accommodate myopia-control lenses, ensuring that kids’ eye health is a priority without compromising on style. The correct adjustment of the temples and nose pads plays a crucial role in managing myopia over time, making Hooper Creatr a blend of fashion, function, and long-term eye care.

Available in a variety of shapes, including rectangles, rounds, and geometric designs, and crafted in both plastic and metal fronts, Hooper Creatr offers options for every child’s unique personality and fit.

Peyush Bansal, Founder &CEO of Lenskart, shared his personal connection to the project: “As a parent, I know how important it is to make eyewear both practical and enjoyable for kids. Hooper Creatr is a project very close to my heart because it’s not just about vision correction—it’s about giving children the opportunity to express themselves through their glasses. We’ve designed Hooper Creatr to grow with kids, ensuring that their frames are not only comfortable today but also supportive of their eye health in the long run as they manage myopia.”